Clinical Trials Browser

Phase 1/2 × Gastrointestinal Stromal Tumors × spartalizumab × Clear all

NCT03609424 2023-01-03

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Phase 1/2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors